CRISPR Applications in Medicine Depend on Minimizing Off-Target Editing

Abstract

Get full access to this article

View all access options for this article.

References

Ledford

. Quest to use CRISPR against disease gains ground. Nature , 2020; 577(7789): 156. DOI: doi: 10.1038/d41586-019-03919-0.

Chaudhari

, Penterman

, Whitton

et al., Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods. CRISPR J. , 2020; 3(6): 440–453. DOI: 10.1089/ crispr.2020.0053.

Tsai

, Zheng

, Nguyen

et al., GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. , 2015; 33(2): 187–197. DOI: 10.1038/ nbt.3117.

Schubert

, Rettig

, Kurgan

et al., Evaluate CRISPR-Cas9 edits quickly and accurately with rhAmpSeq targeted sequencing. Application note. Integrated DNA Technologies. https://go.idtdna.com/rhAmpSeqCRISPR.html.

Daher

, Basar

, Gokdemir

et al., Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. Blood , 2021; 137(5): 624–636. DOI: 10.1182/ blood.2020007748.

Shapiro

, Iancu

, Jacobi

et al., Increasing CRISPR Efficiency and Measuring Its Spec-ificity in HSPCs Using a Clinically Relevant System. Mol. Ther. Methods Clin. Dev. , 2020; 17: 1097–1107. DOI: 10.1016/j.omtm.2020.04.027.